Beyond COVID-19: the promise of next-generation coronavirus vaccines – Nature.com

Ghattas, M., Dwivedi, G., Lavertu, M. & Alameh, M. G. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines (Basel) 9, https://doi.org/10.3390/vaccines9121490 (2021).

Beverley, P. C. Immunology of vaccination. Br. Med. Bull. 62, 1528 (2002).

Article CAS PubMed Google Scholar

Tyrrell, D. A. & Bynoe, M. L. Cultivation Of A Novel Type Of Common-Cold Virus In Organ Cultures. Br. Med. J. 1, 14671470 (1965).

Article CAS PubMed PubMed Central Google Scholar

Hamre, D. & Procknow, J. J. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 121, 190193 (1966).

Article CAS PubMed Google Scholar

van der Hoek, L. et al. Identification of a new human coronavirus. Nat. Med. 10, 368373 (2004).

Article PubMed PubMed Central Google Scholar

Woo, P. C. et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79, 884895 (2005).

Article CAS PubMed PubMed Central Google Scholar

Zhong, N. S. et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, Peoples Republic of China, in February, 2003. Lancet 362, 13531358 (2003).

Article CAS PubMed PubMed Central Google Scholar

Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 18141820 (2012).

Article CAS PubMed Google Scholar

Ye, Z. W. et al. Zoonotic origins of human coronaviruses. Int. J. Biol. Sci. 16, 16861697 (2020).

Article CAS PubMed PubMed Central Google Scholar

Xie, X. et al. Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine. Cell Rep. 41, 111729 (2022).

Article CAS PubMed PubMed Central Google Scholar

Liu, Y. et al. Neutralizing Activity of BNT162b2-Elicited Serum. N. Engl. J. Med. 384, 14661468 (2021).

Article PubMed Google Scholar

Evans, J. P. et al. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci. Transl. Med. 14, eabn8057 (2022).

Article CAS PubMed Google Scholar

Kurhade, C. et al. Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection. Emerg. Microbes Infect. 11, 18281832 (2022).

Article CAS PubMed PubMed Central Google Scholar

Andrews, N. et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N. Engl. J. Med. 386, 15321546 (2022).

Article CAS PubMed Google Scholar

Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657663 (2022).

Article CAS PubMed Google Scholar

Lau, J. J. et al. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nat. Med. 29, 348357 (2023).

Article CAS PubMed PubMed Central Google Scholar

Bar-On, Y. M. et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. N. Engl. J. Med. 385, 13931400 (2021).

Article CAS PubMed Google Scholar

Burckhardt, R. M., Dennehy, J. J., Poon, L. L. M., Saif, L. J. & Enquist, L. W. Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters. J. Virol. 96, e0197321 (2022).

Article PubMed Google Scholar

Corbett, K. S. et al. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccineboosted nonhuman primates. Science 374, 13431353 (2021).

Article CAS PubMed Google Scholar

Tai, W. et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 17, 613620 (2020).

Article CAS PubMed PubMed Central Google Scholar

Premkumar, L. et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci. Immunol. 5, https://doi.org/10.1126/sciimmunol.abc8413 (2020).

Chan, J. F. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9, 221236 (2020).

Article CAS PubMed PubMed Central Google Scholar

Sharifkashani, S. et al. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur. J. Pharmacol. 884, 173455 (2020).

Article CAS PubMed PubMed Central Google Scholar

Mao, T. et al. Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science 378, eabo2523 (2022).

Article CAS PubMed PubMed Central Google Scholar

Port, J. R. et al. Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters. Nat. Commun. 14, 6592 (2023).

Article CAS PubMed PubMed Central Google Scholar

Brown, C. M. et al. Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021. MMWR Morb. Mortal. Wkly Rep. 70, 10591062 (2021).

Article CAS PubMed PubMed Central Google Scholar

Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 22, 183195 (2022).

Article CAS PubMed PubMed Central Google Scholar

Li, X. et al. Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice. Emerg. Microbes Infect. 11, 18901899 (2022).

Article CAS PubMed PubMed Central Google Scholar

Sui, Y. et al. Adjuvanted subunit intranasal vaccine prevents SARS-CoV-2 onward transmission in hamsters. bioRxiv, 2024.2005.2013.593816, https://doi.org/10.1101/2024.05.13.593816 (2024).

McMahan, K. et al. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques. Nature 626, 385391 (2024).

Article CAS PubMed Google Scholar

Woo, P. C. Y. et al. ICTV Virus Taxonomy Profile: Coronaviridae 2023. J Gen Virol 104, https://doi.org/10.1099/jgv.0.001843 (2023).

Lai, M. M. & Cavanagh, D. The molecular biology of coronaviruses. Adv. Virus Res. 48, 1100 (1997).

Article CAS PubMed PubMed Central Google Scholar

Neuman, B. W. et al. A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol. 174, 1122 (2011).

Article CAS PubMed Google Scholar

de Groot, R. J. Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses. Glycoconj. J. 23, 5972 (2006).

Article PubMed PubMed Central Google Scholar

Woo, P. C. Y., Huang, Y., Lau, S. K. P. & Yuen, K. Y. Coronavirus genomics and bioinformatics analysis. Viruses 2, 18041820 (2010).

Article CAS PubMed PubMed Central Google Scholar

Haring, J. & Perlman, S. Mouse hepatitis virus. Curr. Opin. Microbiol 4, 462466 (2001).

Article CAS PubMed PubMed Central Google Scholar

Stohlman, S., Bergmann, C. & Perlman, S. (John Wiley & Sons, Ltd. New York, 1998).

Bradburne, A. F., Bynoe, M. L. & Tyrrell, D. A. Effects of a new human respiratory virus in volunteers. Br. Med J. 3, 767769 (1967).

Article CAS PubMed PubMed Central Google Scholar

Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 10171032 (2020).

Article CAS PubMed Google Scholar

He, J., Guo, Y., Mao, R. & Zhang, J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and metaanalysis. J. Med. Virol. 93, 820830 (2021).

Article CAS PubMed Google Scholar

Ki, M. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiology and health 42 (2020).

Nishiura, H. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int. J. Infect. Dis. 94, 154155 (2020).

Article CAS PubMed PubMed Central Google Scholar

Gao, Z. et al. A systematic review of asymptomatic infections with COVID-19. J. Microbiol., Immunol. Infect. 54, 1216 (2021).

Article CAS PubMed Google Scholar

Sayampanathan, A. A. et al. Infectivity of asymptomatic versus symptomatic COVID-19. Lancet 397, 9394 (2021).

Article CAS PubMed Google Scholar

Khan, S. et al. COVID-19: Clinical aspects and therapeutics responses. Saudi Pharm. J. 28, 10041008 (2020).

Article CAS PubMed PubMed Central Google Scholar

Da Silva, E. et al. An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function. Curr. Res Toxicol. 2, 225236 (2021).

Article PubMed PubMed Central Google Scholar

Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 10331034 (2020).

Article CAS PubMed PubMed Central Google Scholar

Channappanavar, R. & Perlman, S. In Seminars in immunopathology. 529-539 (Springer).

Peiris, J. S. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 17671772 (2003).

Article CAS PubMed PubMed Central Google Scholar

Wong, C. K. et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136, 95103 (2004).

Article CAS PubMed PubMed Central Google Scholar

Kwok, K. O. et al. Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region. Respirology 26, 322333 (2021).

Article PubMed PubMed Central Google Scholar

Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133146 (2023).

Article CAS PubMed PubMed Central Google Scholar

Villarreal, L. P. In Encyclopedia of Virology (Third Edition) (eds Brian W. J. Mahy & Marc H. V. Van Regenmortel) 174-184 (Academic Press, 2008).

Robson, F. et al. Coronavirus RNA proofreading: molecular basis and therapeutic targeting. Mol. cell 79, 710727 (2020).

Article CAS PubMed PubMed Central Google Scholar

Read more from the original source:

Beyond COVID-19: the promise of next-generation coronavirus vaccines - Nature.com